SARS-CoV-2 variants are evolving new ways to evade antibodies and vaccines

By | December 9, 2021
Continued replication of severe acute respiratory syndrome-associated coronavirus 2 (SARS-CoV-2) under selective pressure from natural and vaccine-induced immunity has led to the emergence of variants of concern (VOCs) with increased transmissibility or virulence.